BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2016
View Archived Issues
Medigene cleared to advance DC vaccine trial to phase II
Read More
Prous Institute announces new research collaboration agreement with Broad Institute
Read More
MIN-202 well tolerated and improves symptoms of depression in phase I study
Read More
First patient dosed in phase I trial of ADCT-402 in patients with B-NHL
Read More
Grant supports esophageal cancer screening study at Fred Hutchinson Cancer Research Center
Read More
FDA approves Xalkori for ROS1-positive metastatic NSCLC
Read More
Takeda Pharmaceutical patents HDAC6 inhibitors
Read More
Award supports Biosceptre's preclinical work in kidney and lung cancers
Read More
Astellas Pharma discloses muscarinic M3 receptor PAMs
Read More
EpiTherapeutics describes lysine-specific demethylase inhibitors
Read More
Sunnylife Pharma presents 5-HT2C receptor agonists
Read More
Oncology Venture initiates APO-010 screening study
Read More
University of Virginia reports RUNX1 inhibitors
Read More
First human data for HT-3951
Read More
BMS reports data on BMS-986142
Read More
AbbVie initiates phase III clinical studies to evaluate ABT-493/ABT-530
Read More
Efficacy of endoxifen in bipolar disorder
Read More
GNI submits IND to initiate clinical trials of F-351 for liver fibrosis
Read More
Roche launches DISCOVERY Yellow Kit
Read More
FDA approves Spectrum Pharmaceuticals' Evomela
Read More
Ozgene knock-in mouse model to help advance diabetes research at University of Auckland
Read More
MSD KK files application for approval of oral agents for chronic hepatitis C in Japan
Read More
FDA grants orphan drug designation to dianhydrogalacticol for the treatment of medulloblastoma
Read More